"difference in the trial results regarding the Anaemia"
Are you seriously entertaining the idea that Oncosil should be used to treat Anaemia... or that at the very least use Oncosil in addition to Gem+abr because, according to you, oncosil attenuates anaemia in the LAPC population undergoing Gem+abr treatment?
"It would not take a Oncologist to spot this a normal GP would spot this a mile away and I suggest BSI did to ." I've seen no discussion anywhere regarding this, Oncosil hasn't picked up on it either:
"No evidence to suggest significant additional risk when OncoSil™ is used with contemporary systemic chemotherapy regimens Overall safety profile largely consistent with that expected in a high-risk population receiving chemotherapy. The acceptability of the current safety profile has been confirmed by the independent Safety Review Committee which has met on four occasions since commencement of the study to scrutinise the accumulating safety dataset. " Oncosil 2018
And to end with "To start of with the overall survival rate using Oncosil has yet to be determined , it’s still increasing ," Can you please substantiate the above statement of fact?
As far as I am aware, the OS was the same in the interim analysis report and updated CER... as informed by Oncosil themselves.
OSL Price at posting:
14.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)